Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Adult Patients with t(4;11)(q21;q23) KMT2A/AFF1 (MLL/AF4) B-Acute Lymphoblastic Leukemia in First Complete Remission (CR1): Favorable Outcome of Patients with Negative Minimal Residual Disease (MRD) Status at Transplant. a Report from the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation (ALWP-EBMT)

Blood (2017) 130 (Supplement 1): 669.

https://doi.org/10.1182/blood.V130.Suppl_1.669.669

Published: 2017

Journal Articles

The Role of Total Body Irradiation (TBI) in the High-Dose Regimen of Patients with Follicular Lymphoma (FL) Treated with Autologous Stem Cell Transplant (ASCT) in the Rituximab Era. A Retrospective Study of the EBMT Lymphoma Working Party

Blood (2011) 118 (21): 502.

https://doi.org/10.1182/blood.V118.21.502.502

Published: 2011

Journal Articles

Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia (AML) with 11q23 (MLL) Rearrangement (MLL-r AML). A Retrospective Analysis From the Acute Leukemia Working Party of EBMT

Arnaud Pigneux, MD, PhD, Myriam Labopin, MD, MS, Johann Maertens, MD, Ulrike Bacher, MD, Gérard Socié, Catherine Cordonnier, Noel-Jean Milpied, MD, Jean-Pierre Jouet, MD, Bernard Rio, MD, Didier Blaise, MD, Jordi Esteve, MD, Mohamad Mohty

Blood (2011) 118 (21): 498.

https://doi.org/10.1182/blood.V118.21.498.498

Published: 2011

Journal Articles

Grafts From HLA-Identical Siblings Versus HLA-Allelic-Matched Unrelated Donors (10/10) In Patients Undergoing Allogeneic Stem Cell Transplantation Following Reduced-Intensity Conditioning Regimen

Eva De Berranger, Mathieu Wemeau, Charles Herbaux, Cracco Pascale, Jean-Pierre Jouet, MD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2010) 116 (21): 2380.

https://doi.org/10.1182/blood.V116.21.2380.2380

Published: 2010

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation In Early Phase Might Overcome the Adverse Prognosis of Acute Myeloid Leukemia with Translocation t(6;9)(p23;q34)/DEK-NP214(CAN) Rearrangement. A Retrospective Analysis From the Acute Leukemia Working Party of EBMT

Jordi Esteve, MD, Myriam Labopin, MD, Gerard Socie, MD, PhD, Per T. Ljungman, MD, PhD, Johan Maertens, Antonius V.M.B. Schattenberg, MD, PhD, Sebastien Maury, MD, Jean-Pierre Jouet, MD, Emmanuelle Polge, Vanderson Rocha, Mohamad Mohty, MD, PhD

Blood (2010) 116 (21): 3501.

https://doi.org/10.1182/blood.V116.21.3501.3501

Published: 2010

Journal Articles

Matched Unrelated Donor Transplantation Is Curative In Selected Patients with Diffuse Large B Cell Lymphoma: A Report of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT)

Irit Avivi, MD, Carmen Canals, Jian Jian Luan, Gerald. G. Wulf, Arnon Nagler, M.D., Agnes Buyzin, Eefke J. Petersen, MD, PhD, Jean-Pierre Jouet, MD, Donald Milligan, MD, FRCP, FRCPath, Anton Schattenberg, MD, Dietger W Niederwieser, MD, Kirsty Thomson, Didier Blaise, MD, Michel Attal, Gerhard Held, MD, Peter Dreger, MD, PhD, Anna Sureda, MD, PhD

Blood (2010) 116 (21): 363.

https://doi.org/10.1182/blood.V116.21.363.363

Published: 2010

Journal Articles

Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT

Blood (2010) 116 (21): 688.

https://doi.org/10.1182/blood.V116.21.688.688

Published: 2010

Journal Articles

Nilotinib as Salvage Therapy In Patients with Chronic Graft Versus Host Disease

Louis Terriou, Leonardo Magro, Eva De Berranger, Jean-Pierre Jouet, MD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2010) 116 (21): 2329.

https://doi.org/10.1182/blood.V116.21.2329.2329

Published: 2010

Journal Articles

Allogeneic Stem Cell Transplantation From Unrelated One-Antigen HLA-Mismatched Donor, Increases Acute II-IV Gvhd Incidence without Interfering with Other Post-Transplant Complications

Eva De Berranger, Louis Terriou, Valérie Coiteux, Leonardo Magro, Françoise Dufossé, Jean-Pierre Jouet, MD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2010) 116 (21): 2378.

https://doi.org/10.1182/blood.V116.21.2378.2378

Published: 2010

Journal Articles

Early Human Herpes Virus Type 6 Reactivation in Patients Undergoing Allogeneic Stem Cell Transplantation (allo-SCT).

Remy Dulery, Anny Dewilde, Julie Gay, MD, Julien Rossignol, Louis Terriou, Valerie Coiteux, MD, Jean-Pierre Jouet, MD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2009) 114 (22): 794.

https://doi.org/10.1182/blood.V114.22.794.794

Published: 2009

Journal Articles

Peripheral Blood Stem Cell (PBSC) Harvest Is More Expensive Following Bortezomib-Based Therapy in Multiple Myeloma (MM), Related to Increase Number of Days of Collect.

Matthieu Barthelemy, Florence Boulanger, MD, Houria Debarri, Laurent Pascal, Pierre Samarcq, MD, Colette Cossement, MD, Jean-Pierre Jouet, MD, Thierry Facon, MD, Ibrahim Yakoub-Agha, MD, PhD, Xavier Leleu

Blood (2009) 114 (22): 1373.

https://doi.org/10.1182/blood.V114.22.1373.1373

Published: 2009

Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplantation for Follicular Lymphoma Results in An Improved Progression Free Survival When Compared to Autologous Stem Cell Transplantation. An Analysis from the Lymphoma Working Party of the EBMT

Stephen P Robinson, Carmen Canals, Didier Blaise, MD, Kirsty Thomson, Robert Foa, Arturo Iriondo Atienza, Jean-Luc Harousseau, Catherine Cordonnier, MD, Gordon Cook, MD, PhD, Jean-Pierre Jouet, MD, Jean-Yves Cahn, MD, PhD, Charles Crawley, Michel Attal, MD, Marek Trneny, MD, PhD, H. Tilly, Anna Sureda, MD

Blood (2008) 112 (11): 458.

https://doi.org/10.1182/blood.V112.11.458.458

Published: 2008

Journal Articles

Identification of Prognostic Factors Predicting the Outcome of Reduced Intensity Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma. An Analysis from the Lymphoma Working Party of the EBMT

Stephen P Robinson, Anna Sureda, Carmen Canals, Sr., Jean-Paul Vernant, Noel-Jean Milpied, PhD, Jürgen Finke, Johan Maertens, Jean-Pierre Jouet, MD, Charles F. Craddock, BM, MRCP, MRCPath, Karl S Peggs, MD, Steven Le Gouill, MD, Norbert Schmitz, MD, PhD

Blood (2008) 112 (11): 457.

https://doi.org/10.1182/blood.V112.11.457.457

Published: 2008

Journal Articles

Improvement of Supportive Care in Patients Undergoing Myeloablative Allogeneic Stem Cell Transplantation Not Only Reduces Transplant-Related Mortality but Also Increases Long-Term Survival

Benedicte Bruno, MD, David Seguy, MD, Vincent Maunoury, MD, PhD, Valerie Coiteux, MD, Leonardo Magro, MD, Francis Bauters, MD, Francoise Mazingue, MD, Jean-Pierre Jouet, MD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2008) 112 (11): 4318.

https://doi.org/10.1182/blood.V112.11.4318.4318

Published: 2008

Journal Articles

Wireless Video-Capsule Endoscopy Is a More Sensitive Investigative Method Than Gastro-Intestinal Endoscopy and Biopsies for the Diagnosis of Acute GI-Gvhd.

Jean-Baptiste Micol, Valerie Coiteux, MD, Laurent Pascal, Louis Terriou, Christophe Willekens, Jean-Pierre Jouet, MD, Vincent Maunoury, MD, PhD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2008) 112 (11): 1123.

https://doi.org/10.1182/blood.V112.11.1123.1123

Published: 2008

Journal Articles

Efficacy of Imatinib Mesylate in the Treatment of Refractory Sclerodermatous Chronic Graft-Versus-Host Disease.

Ibrahim YakoubAgha, MD, PhD, Leonardo Magro, MD, Benoit Catteau, MD, Christophe Willekens, Valerie Coiteux, MD, Benedicte Bruno, MD, Louis Terriou, Jean-Pierre Jouet, MD

Blood (2008) 112 (11): 2141.

https://doi.org/10.1182/blood.V112.11.2141.2141

Published: 2008

Journal Articles

Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLCL). A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) Registry.

Anne Sirvent, MD, Michael Hummelsberger, MD, Zina Chir, Nathalie Dhedin, MD, Catherine Faucher, MD, Jean-Pierre Jouet, MD, Michel Attal, MD, Patrice Chevalier, MD, Marie Robin, MD, Reza Tabrizi, MD, Pierre Bordigoni, MD, Jean-Henri Bourhis, MD, Agnes Buzyn, MD, Nathalie Contentin, MD, Jerome Cornillon, MD, Frederic Garban, MD, Mauricette Michallet, MD

Blood (2006) 108 (11): 2946.

https://doi.org/10.1182/blood.V108.11.2946.2946

Published: 2006

Journal Articles

A Retrospective 20-Year Survey of the Incidence of Chronic Myeloid Leukemia in the Northern France Region.

Selim Corm, MD, Ariane Leroyer, MD, Mathieu Wemeau, MD, Bruno Bregman, PhD, Abderrahim Oukessou, MD, Claude Preudhomme, MD, PhD, Jean-Pierre Jouet, MD, Jean-Luc Lai, PhD, Thierry Facon, MD

Blood (2006) 108 (11): 4798.

https://doi.org/10.1182/blood.V108.11.4798.4798

Published: 2006

Journal Articles

A Retrospective Survey of Imatinib Mesylate Treatment for Chronic Myeloid Leukemia in a Northern France Region.

Selim Corm, MD, Ariane Leroyer, MD, Mathieu Wemeau, MD, Bruno Bregman, PhD, Abderrahim Oukessou, MD, Michiel Hemels, MD, Claude Preudhomme, MD, PhD, Jean-Pierre Jouet, MD, Jean-Luc Lai, PhD, Thierry Facon, MD

Blood (2006) 108 (11): 4800.

https://doi.org/10.1182/blood.V108.11.4800.4800

Published: 2006

Journal Articles

Quantification by Magnetic Resonance Imaging (MRI) and Consequences of Post-Transfusionnal Iron Overload in Long Bone Marrow Transplant Survivors.

Christian Rose, MD, Olivier Ernst, PD, Bernard Hecquet, MD, Pascale Renom, MD, Marie Pierre Noel, MD, Ibrahim Yakoub-Agha, MD, Emmanuelle Bourgeois, MD, Nathalie Cambier, MD, Francis Bauters, MD, Jean Pierre Jouet, MD

Blood (2005) 106 (11): 1112.

https://doi.org/10.1182/blood.V106.11.1112.1112

Published: 2005

NARROW

The Role of Total Body Irradiation (TBI) in the High-Dose Regimen of Patients with Follicular Lymphoma (FL) Treated with Autologous Stem Cell Transplant (ASCT) in the Rituximab Era. A Retrospective Study of the EBMT Lymphoma Working Party

Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia (AML) with 11q23 (MLL) Rearrangement (MLL-r AML). A Retrospective Analysis From the Acute Leukemia Working Party of EBMT

Grafts From HLA-Identical Siblings Versus HLA-Allelic-Matched Unrelated Donors (10/10) In Patients Undergoing Allogeneic Stem Cell Transplantation Following Reduced-Intensity Conditioning Regimen

Allogeneic Hematopoietic Stem-Cell Transplantation In Early Phase Might Overcome the Adverse Prognosis of Acute Myeloid Leukemia with Translocation t(6;9)(p23;q34)/DEK-NP214(CAN) Rearrangement. A Retrospective Analysis From the Acute Leukemia Working Party of EBMT

Matched Unrelated Donor Transplantation Is Curative In Selected Patients with Diffuse Large B Cell Lymphoma: A Report of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT)

Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT

Nilotinib as Salvage Therapy In Patients with Chronic Graft Versus Host Disease

Allogeneic Stem Cell Transplantation From Unrelated One-Antigen HLA-Mismatched Donor, Increases Acute II-IV Gvhd Incidence without Interfering with Other Post-Transplant Complications

Early Human Herpes Virus Type 6 Reactivation in Patients Undergoing Allogeneic Stem Cell Transplantation (allo-SCT).

Peripheral Blood Stem Cell (PBSC) Harvest Is More Expensive Following Bortezomib-Based Therapy in Multiple Myeloma (MM), Related to Increase Number of Days of Collect.

Reduced Intensity Allogeneic Stem Cell Transplantation for Follicular Lymphoma Results in An Improved Progression Free Survival When Compared to Autologous Stem Cell Transplantation. An Analysis from the Lymphoma Working Party of the EBMT

Identification of Prognostic Factors Predicting the Outcome of Reduced Intensity Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma. An Analysis from the Lymphoma Working Party of the EBMT

Improvement of Supportive Care in Patients Undergoing Myeloablative Allogeneic Stem Cell Transplantation Not Only Reduces Transplant-Related Mortality but Also Increases Long-Term Survival

Wireless Video-Capsule Endoscopy Is a More Sensitive Investigative Method Than Gastro-Intestinal Endoscopy and Biopsies for the Diagnosis of Acute GI-Gvhd.

Efficacy of Imatinib Mesylate in the Treatment of Refractory Sclerodermatous Chronic Graft-Versus-Host Disease.

Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLCL). A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) Registry.

A Retrospective 20-Year Survey of the Incidence of Chronic Myeloid Leukemia in the Northern France Region.

A Retrospective Survey of Imatinib Mesylate Treatment for Chronic Myeloid Leukemia in a Northern France Region.

Quantification by Magnetic Resonance Imaging (MRI) and Consequences of Post-Transfusionnal Iron Overload in Long Bone Marrow Transplant Survivors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only